Addex Fundamentals

ADXN Stock

USD 1.16 0.10 9.43%

Addex Therapeutics fundamentals help investors to digest information that contributes to Addex Therapeutics' financial success or failures. It also enables traders to predict the movement of Addex Stock. The fundamental analysis module provides a way to measure Addex Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Addex Therapeutics stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Addex Therapeutics Gross Profit is very stable at the moment as compared to the past year. Addex Therapeutics reported last year Gross Profit of 2.62 Million. As of 24th of March 2023, Interest Expense is likely to grow to about 74.4 K, while Consolidated Income is likely to drop (14.9 M).

Current Assets Total Assets

Addex Beta Analysis

Addex Therapeutics' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it will be expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

	2020	2021	2022	2023 (projected)
Interest Expense	650.63 K	63.01 K	72.46 K	74.37 K
Gross Profit	3.61 M	2.92 M	2.62 M	3 M

Interest Expense Gross Profit

Beta

Covariance

Variance

More About Beta | All Equity Analysis

Current Addex Therapeutics Beta

1.77

Most of Addex Therapeutics' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Addex Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

Competition

Predict Addex Therapeutics

In accordance with the recently published financial statements, Addex Therapeutics has a Beta of 1.7729. This is 106.15% higher than that of the Healthcare sector and 27.55% higher than that of the Biotechnology industry. The beta for all United States stocks is notably lower than that of the firm.

Addex Therapeutics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Addex Therapeutics's current stock value. Our valuation model uses many indicators to compare Addex Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Addex Therapeutics competition to find correlations between indicators driving Addex Therapeutics's intrinsic value. More Info.

Addex Therapeutics is number one stock in return on asset category among related companies. It is number one stock in return on equity category among related companies . As of 24th of March 2023, Average Equity is likely to grow to about 17.2 M. Comparative valuation analysis is a catch-all model that can be used if you cannot value Addex Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Addex Therapeutics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Addex Therapeutics' earnings, one of the primary drivers of an investment's value.

Addex Number of Employees Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Addex Therapeutics' direct or indirect competition against its Number of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Addex Therapeutics could also be used in its relative valuation, which is a method of valuing Addex Therapeutics by comparing valuation metrics of similar companies.

Addex Therapeutics is currently under evaluation in number of employees category among related companies.

Addex Therapeutics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Addex Therapeutics from analyzing Addex Therapeutics' financial statements. These drivers represent accounts that assess Addex Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Addex Therapeutics' important valuation drivers and their relationship over time.

	2018	2019	2020	2021	2022	2023 (projected)
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	(1.42 M)	(14.23 M)	(11.83 M)	(14.94 M)	(13.45 M)	(14.51 M)
Earnings Before Interest Taxes and Depreciation Amortization USD	(1.45 M)	(14.67 M)	(13.44 M)	(16.42 M)	(14.78 M)	(15.94 M)
Earnings before Tax	(1.64 M)	(14.78 M)	(12.86 M)	(15.35 M)	(13.82 M)	(14.91 M)
Free Cash Flow	1.74 M	(9.51 M)	(12.24 M)	(14.74 M)	(13.26 M)	(13.61 M)
Invested Capital	(1.79 M)	(3.64 M)	(1.57 M)	(1.6 M)	(1.44 M)	(1.55 M)
Tangible Asset Value	42.21 M	33.03 M	20.18 M	22.54 M	25.92 M	27.66 M
Working Capital	39.82 M	26.71 M	15.87 M	17.81 M	20.48 M	22.56 M

Addex Fundamentals

	Return On Equity	(2.03) %
	Return On Asset	(0.88) %
	Operating Margin	(17.07) %
	Current Valuation	3.12 M
	Shares Outstanding	19.22 M
	Shares Owned by Institutions	20.74 %
	Number of Shares Shorted	338.7 K
	Price to Book	1.41 X
	Price to Sales	10.28 X
	Revenue	2.92 M
	Gross Profit	(9.69 M)
	EBITDA	(14.94 M)
	Net Income	(15.35 M)
	Cash and Equivalents	8.81 M
	Cash per Share	1.40 X
	Total Debt	336.95 K
	Debt to Equity	0.049 %
	Current Ratio	2.55 X
	Book Value Per Share	0.90 X
	Cash Flow from Operations	(14.71 M)
	Short Ratio	0.61 X
	Earnings Per Share	(3.44) X
	Number of Employees	26
	Beta	1.77
	Market Capitalization	26.73 M
	Total Asset	22.54 M
	Retained Earnings	(324.6 M)
	Working Capital	27.2 M
	Current Asset	32.02 M
	Current Liabilities	4.82 M
	Z Score	29.0
	Net Asset	22.54 M

About Addex Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Addex Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Addex Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Addex Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

	Last Reported	Projected for 2023
Deferred Revenue	77.8 K	79.9 K
Revenues	2.6 M	3 M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Addex Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Addex Therapeutics' short interest history, or implied volatility extrapolated from Addex Therapeutics options trading.

Pair Trading with Addex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Addex Therapeutics

-	0.71	ABIO	ARCA Biopharma	Fiscal Quarter End 31st of March 2023	Pair Corr
-	0.61	ACLX	Arcellx	Financial Report 11th of May 2023	Pair Corr
-	0.53	ABEO	Abeona Therapeutics	Earnings Call This Week	Pair Corr
-	0.51	ABCM	AbcamPLC		Pair Corr
-	0.51	ABTI	Alterola Biotech		Pair Corr

The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.

The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out Addex Therapeutics Piotroski F Score and Addex Therapeutics Altman Z Score analysis. To learn how to invest in Addex Stock please use our How to Invest in Addex Therapeutics guide. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for analysis

When running Addex Therapeutics price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.

	ETF Directory Find actively traded Exchange Traded Funds (ETF) from around the world
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets

Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.44)

Revenue Per Share

0.186

Quarterly Revenue Growth

(0.45)

Return On Assets

(0.88)

Return On Equity

(2.03)

The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Addex Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

Addex Fundamentals

Addex Beta Analysis

Current Addex Therapeutics Beta

Addex Therapeutics Fundamental Drivers Relationships

Addex Number of Employees Peer Comparison

Addex Therapeutics Current Valuation Drivers

Addex Fundamentals

About Addex Therapeutics Fundamental Analysis

Pair Trading with Addex Therapeutics

Moving against Addex Therapeutics

Complementary Tools for analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY